Table 1.
Baseline patient characteristics
| Total | Surgery | P-Value | ||||
|---|---|---|---|---|---|---|
| Trabeculectomy | PT | AGV | PE | |||
| Eye | ||||||
| OD | 48 (53.9%) | 12 (52.2%) | 13 (57%) | 10 (58.8%) | 13 (50%) | 0.948* |
| OS | 41 (46.1%) | 11 (47.8%) | 10 (43%) | 7 (41.2%) | 13 (50%) | |
| Sex | ||||||
| Male | 56 (63%) | 15 (65.2%) | 18 (78%) | 13 (76.5%) | 13 (50%) | 0.088* |
| Female | 34 (37%) | 8 (34.8%) | 5 (22%) | 4 (23.5%) | 13 (50%) | |
| Age | 57.9±21.1 | 54.7±24.2 | 60.2±20.2 | 46.9±22.1 | 66.2±16.2 | 0.150 |
| VCDR | 0.74±0.27 | 0.91±0.07 | 0.88±0.1 | 0.92±0.1 | 0.37±0.17 | <0.001‡ |
| Pre-op CRF | 8.4±1.5 | 7.7±1.9 | 8.5±0.8 | 8.7±1.7 | 8.7±1.2 | 0.835‡ |
| Pre-op CH | 6.2±2.3 | 5.4±1.8 | 5.3±1.7 | 5.2±2.6 | 8.1±1.8 | <0.001‡ |
| CCT | 540±23 | 536±23 | 546±26 | 547±27 | 537±19 | 0.655‡ |
*
Based on Chi-Square test
‡
Based on ANOVA
PT, phaco-trabeculectomy; AGV, Ahmed glaucoma valve implantation; PE, phacoemulsification; OD, right eye; OS, left eye; VCDR, vertical cup to disc ratio; CRF, corneal resistant factor; CH, corneal hysteresis; CCT, central corneal thickness